Cash Position & Operating Runway : As of December 31, 2024, ARS Pharma had cash, cash equivalents, and short-term investments of $314.0 million, with 97,954,172 shares of common stock outstanding. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback